Option Care Health
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion...
Latest News
13 days ago · zacks.com
Option Care (OPCH) Q3 Earnings and Revenues Surpass EstimatesOption Care (OPCH) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.45 per share a year ago.
13 days ago · globenewswire.com
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026BANNOCKBURN, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2026.
13 days ago · prnewswire.com
Are OPCH, PTC, RXO Obtaining Fair Deals for their Shareholders?/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
17 days ago · businesswire.com
OPCH Stock Alert: Halper Sadeh LLC is Investigating Whether Option Care Health, Inc. is Obtaining a Fair Price for its ShareholdersNEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Option Care Health, Inc. (NASDAQ: OPCH) to CD&R, McKesson Corporation for $32.05 per share. Halper Sadeh encourages Option Care shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Option Care and its board of.
1 month ago · globenewswire.com
OPCH Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Option Care Health to CD&R and McKessonMONSEY, N.Y., Oct. 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Option Care Health, Inc. (NASDAQ: OPCH) (“OPCH”) to CD&R and McKesson Corporation for $32.05 per share in cash.
1 month ago · gurufocus.com
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 12, 2026Insiders may stand to receive substantial financial bene
1 month ago · benzinga.com
This Option Care Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For WednesdayTop Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
1 month ago · zacks.com
Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
1 month ago · fool.com
Why Option Care Health Stock Skyrocketed on TuesdayOption Care is being bought out by McKesson and private equity firm Clayton Dubilier & Rice. The deal values Option Care at $32.05 per share or about $5.8 billion.
1 month ago · zacks.com
Is Option Care Health (OPCH) Stock Undervalued Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove OPCH